SRT Therapeutics Revenue

Biotechnology Research • San Diego, California, United States • 11-20 Employees

SRT Therapeutics revenue & valuation

Annual revenue	$1,283,325
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,200,000
Total funding	$47,400,000

Key Contacts at SRT Therapeutics

Matthew Denholtz

Director, Computational Biology

Rafael Rojas

Staff Scientist/Director

April May

Senior Director, Finance/Controller

Alec Witty

Senior Director Of Research And Operations

Janine Bilsborough

Scientific Founder & Consultant

Lauren Otsuki

Chief Executive Officer

Company overview

Headquarters	San Diego, California, United States
Website	srt-tx.com
NAICS	541714
Founded	2024
Employees	11-20

SRT Therapeutics Email Formats

SRT Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@srt-tx.com), used 75% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@srt-tx.com	75%
{first initial}{last name}	jdoe@srt-tx.com	25%

About SRT Therapeutics

SRT Therapeutics is a San Diego-based biotech company established in 2024 by the founders of Prometheus Biosciences, Steph Targan, MD (Cedars Sinai), Janine Bilsborough, Ph.D. (Cedars Sinai), the scientific team that discovered Tulisokibart (MK7240) and the role of TL1A in IBD and Scott Glenn and Lauren Otsuki, the drug development team that took Tulisokibart (MK7240) from academia into the clinic. Building on the demonstrated success of the precision medicine approach in IBD with Tulisokibart, SRT Therapeutics will expand this approach by targeting key pathways that not only modulate inflammatory pathways, but also promote tissue healing in IBD. This strategy will move SRT Therapeutics beyond the current empirical treatment model to realize the goal of enhancing both outcomes and the quality of care for our patients.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

Entry

Senior

Employees by Department

SRT Therapeutics has 6 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore SRT Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2025-09-13	15	$47,400,000

Funding Insights

$47,400,000

Total funding amount

$47,400,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

SRT Therapeutics is located in San Diego, California, US.

SRT Therapeutics generates an estimated annual revenue of $1,283,325. This revenue figure reflects the company's market position and business performance in its industry.

SRT Therapeutics has an estimated valuation of $4,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

SRT Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

SRT Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

SRT Therapeutics has raised a total of $47,400,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.